Valuation: Asahi Kasei Corporation

Market Cap 2,215B 14.08B 12.35B 11.67B 10.63B 19.9B 1,349B 20.04B 140B 54.07B 689B 52.85B 51.71B P/E 2027 *
13.1x
P/E 2028 * 12.1x
Enterprise Value 2,863B 18.19B 15.96B 15.08B 13.74B 25.72B 1,744B 25.91B 180B 69.88B 891B 68.31B 66.83B EV / Sales 2027 *
0.88x
EV / Sales 2028 * 0.83x
Free-Float
96.37%
Yield 2027 *
2.74%
Yield 2028 * 2.99%
09-15 Asahi Kasei Bioprocess Unveils Vantij Su-Vfc Benchtop for Automated Single-Use Virus Filtration CI
09-14 Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan MT
08-26 Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company?s 40-Year North American Battery Separator Strategy CI
08-20 Asahi Kasei Develops Novel Lithium Pre-Doping Technology For Silicon-Rich Lithium-Ion Batteries CI
08-19 Asahi Kasei Expands Capacity For Water Electrolysis And Chlor-Alkali Equipment In Kawasaki CI
08-17 Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025. CI
08-12 Asahi Kasei Corporation's Equity Buyback announced on November 5, 2025, has closed with 22,859,400 shares, representing 1.69% for ¥39,999.9 million. CI
08-06 Asahi Kasei Corporation and Highchem Shanghai Enter First License Agreement for Production and Sale of Acetolyte Novel Electrolyte in China CI
07-31 Asahi Kasei's Attributable Net Income Surges 173% in Fiscal Q1 MT
07-31 Asahi Kasei Corporation Provides Dividend Guidance for the End of Second Quarter of Fiscal Year Ending March 31, 2027 CI
07-31 Asahi Kasei Corporation Provides Consolidated Earnings Guidance for the Six Months and Fiscal Year Ending March 31, 2027 CI
07-31 Asahi Kasei Corporation Provides Dividend Guidance for the End of Fourth Quarter of Fiscal Year Ending March 31, 2027 CI
07-31 Asahi Kasei Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
1 day+1.06%
1 week+3.55%
Current month+2.99%
1 month+2.59%
3 months-4.15%
6 months+7.35%
Current year+18.80%
1 week 20.1
Extreme 20.0984
21.61
1 month 19.66
Extreme 19.6554
21.61
Current year 17.63
Extreme 17.63
24.12
1 year 15.18
Extreme 15.18
24.12
3 years 11.8
Extreme 11.8
24.12
5 years 11.8
Extreme 11.8
24.12
10 years 10.69
Extreme 10.69
31
Manager TitleAgeSince
Director of Finance/CFO - -
President 67 31/03/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 31/03/2022
Director/Board Member 79 31/05/2018
Director/Board Member 67 31/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.06%+3.55% - - 14.08B
-0.24%+0.77%+23.72%+30.20% 69.59B
-3.59%-2.32%+19.79%+17.86% 49.47B
-0.32%-3.49%+1.44%+21.64% 16.11B
+2.43%+2.84%+36.84%+67.65% 14.08B
-0.13%-1.56%+31.52%+19.74% 10.11B
+1.19%-0.63%+19.65%-19.34% 9.8B
-0.45%+1.10%+15.10% - 9.09B
-0.21%+3.33%+109.85%-6.59% 8.95B
+0.19%-1.19%-11.94%+13.13% 7.83B
Average -0.01%-0.13%+27.33%+18.04% 21.67B
Weighted average by Cap. -0.69%-0.35%+24.15%+23.34%

Financials

2027 *2028 *
Net sales 3,271B 20.79B 18.24B 17.23B 15.7B 29.39B 1,992B 29.6B 206B 79.85B 1,018B 78.05B 76.36B 3,367B 21.39B 18.77B 17.73B 16.16B 30.25B 2,050B 30.46B 212B 82.18B 1,048B 80.32B 78.59B
Net income 170B 1.08B 946M 893M 814M 1.52B 103B 1.54B 10.69B 4.14B 52.79B 4.05B 3.96B 184B 1.17B 1.03B 970M 884M 1.65B 112B 1.67B 11.61B 4.5B 57.32B 4.4B 4.3B
Net Debt 648B 4.12B 3.61B 3.41B 3.11B 5.82B 395B 5.86B 40.83B 15.81B 202B 15.46B 15.12B 572B 3.63B 3.19B 3.01B 2.74B 5.13B 348B 5.17B 36.02B 13.95B 178B 13.64B 13.34B
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
47,895
Date Price Change Volume
25/09/26 US$21.02 +1.06% 10,047
24/09/26 US$20.80 +2.54% 49,638
23/09/26 US$20.29 -1.85% 23,894
22/09/26 US$20.67 -0.01% 21,452
21/09/26 US$20.67 +1.82% 24,007
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,645.50JPY
Average target price
1,965.00JPY
Spread / Average Target
+19.42%

Quarterly revenue - Rate of surprise